Autoantibodies to gangliosides in sera of atherosclerotic patients

• Published in: Clinica chimica acta Vol. 272; no. 2; pp. 197 - 207
• Main Authors: Golovanova, Natalia K, V. Gracheva, Elena, Basharova, Lubov A, Kozlov, Sergei G, Lyakishev, Anatoliy A, Prokazova, Nina V, Bergelson, Lev D
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 27-04-1998
• Subjects: Adult; Aged; Antigen-Antibody Reactions; Arteriosclerosis - immunology; Atherosclerosis; Autoantibodies; Autoantibodies - blood; Enzyme-Linked Immunosorbent Assay; Female; G(M3) Ganglioside - immunology; Ganglioside GM3; Humans; Male; Middle Aged; Serotonin; Serotonin - immunology; Ganglioside GM3; Autoantibodies; Serotonin; Atherosclerosis
• ISSN: 0009-8981; 1873-3492
• DOI: 10.1016/S0009-8981(98)00013-8

Using ELISA we studied the levels and clinical correlation of serum antibodies against gangliosides and 5-hydroxytryptamine (5-HT) in patients with atherosclerosis and clinical manifestations of cardiovascular disease. A range of 70–80% of the patients showed higher titers of anti-GM3
(L) and anti-5HT as compared to normal serum. The anti-GM3
(L) antibodies appeared to be directed mainly against GM3 present in platelets and were much less reactive against GM3 isolated from the aorta. We concluded that the antigens responsible for the elevated anti-GM3
(L) and anti 5-HT levels in atherosclerotic sera are released by vessel-wall activated platelets. These results provide further evidence of on-going autoimmune processes in atherosclerosis. The content of total sialic (TS) and lipid-bound sialic acid (LBS) was measured in sera of patients with IHD and of similar numbers of healthy donors. In the patient groups the average TS and LBS concentration was about 25% higher than in the control group. These changes appeared to be associated with higher degrees of protein sialylation and larger amounts of LDL in the patient sera than in those of healthy controls.